...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Almost 1.25 years now

Toinv - I whole heartedly agree however I'm not willing to bet the farm on that playing out the way you suggest it should. A more likely scenario will be a whole lot of scientific talk that we all hope BDAZ can unravel for us and put into language that we can understand. Bear I'm going to meet you one day with a bottle of your favourite beverage. I don't think I could understand half of this without your interpretation.

tada

Share
New Message
Please login to post a reply